Research programme: collagen inhibitors - Avidex
Alternative Names: ReaDexLatest Information Update: 20 Jun 2006
At a glance
- Originator Avidex
- Class
- Mechanism of Action Collagen inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Rheumatoid arthritis
Most Recent Events
- 20 Jun 2006 No development reported - Preclinical for Rheumatoid arthritis in United Kingdom (unspecified route)
- 24 Feb 2004 Preclinical trials in Rheumatoid arthritis in United Kingdom (unspecified route)